Program
#AHA24
Late-Breaking Science
Daily Coverage
Industry Highlights
Photo Gallery
Journeys
AHA23
Watch: Scientific Sessions 2023 Day 2 | Sunday, Nov. 12
AHAtv covers late-breaking science, the Presidential Session and more live from Philadelphia.
AHA23
Getting to the Heart of Stroke™
AHA23
Watch: Scientific Sessions 2023 | Day 1, Saturday, Nov. 11
AHA23
Watch: Scientific Sessions 2023 Pre-Sessions Symposia & Early Career Day
AHA23
Late-breaking science| Achieving equity in prevention
AHA23
Novel mechanisms for lipid-lowering therapy
Editing the PCSK9 gene, first-in-human trial of lepodisiran, new PCSK9 antibody and statins performance in people with HIV highlight four trials.
AHA23
Late-breaking science: AI at the bedside
AI-powered stethoscope, speech analysis for HF, interpreting ECGs with AI and prognostic tool for predicting MACE.
Sponsored
Unmet Needs in Hypertension Toolkit
Learn more about initial management of HTN, diagnosing resistant hypertension, sharing decision-making with your patient and more.
AHA23
Shocking decisions in AFib care
Trials’ results highlight the risks and benefits of oral anticoagulation, the superiority of dual direct cardioversion in patients with obesity and the potential for a novel factor XI inhibitor to reduce bleeding in patients with high risk of stroke.
AHA23
Drugs, diet and delivery can optimize hypertension outcomes
Findings evaluate dietary sodium reduction, postpartum blood pressure, an investigational RNA interference therapeutic agent and BP control and dementia risk.
AHA23
Established lecture to present new research developments
Atrial fibrillation experts examine critical needs and potential therapeutic possibilities for the prevalent condition
AHA23
Artificial intelligence shows promise and pitfalls
AI can be a benefit in cardiovascular care, but a responsible approach is needed
AHA23
Age: Is it a number, or a biology?
Champions of cardiovascular health and investigators in the aging domain unite to address age-old questions and present innovative insights
AHA23
Teamwork matters
AHA23
Heart failure late-breaking science
Trials highlight aspirin-free LVAD regimen, TEAMMATE and POCKET-COST-HF.
AHA23
Changing the course of medicine
Scientists dedicated to the research and results of the polypill share exciting progress and prospects
AHA23
A comprehensive view of cardiogenic shock
AHA23
Metabolic risk factors can complicate kidney, cardiovascular health
AHA23
Q&A With Nobel Laureate Edvard Moser, PhD
AHA23
Looking to TAVI’s future
AHA23
Sudden impact
AHA23
American Heart Association selects six Distinguished Scientists for 2023
AHA23
All in the family
AHA23
Council Awards
AHA23
Packing for Philadelphia
Check weather
AHA23
Watch AHAtv
AHA23
Health Innovation Pavilion and the Health Tech Competition